Related Experiment Video
Updated: Nov 5, 2025

08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.1K
A Virtual Reality-Based Screening Test for Cognitive Impairment in Small Vessel Disease
Hatice Limoncu1, Hatice Eraslan Boz1,2, Stelios Zygouris3,4
1Department of Neurology, School of Medicine, Dokuz Eylul University, Izmir, Turkey.
Journal of Alzheimer'S Disease Reports
|May 13, 2021
Summary
The Virtual Supermarket (VST) shows promise as a practical tool for assessing cognitive impairment in small vessel disease (SVD) patients. This digital assessment effectively differentiates SVD patients with cognitive impairment from healthy controls.
Area of Science:
- Neurology
- Cognitive Science
- Medical Technology
Background:
- Small vessel disease (SVD) poses a significant challenge in clinical settings due to the lack of practical tools for assessing cognitive impairment.
- Cognitive impairment associated with SVD requires effective and accessible assessment methods for timely diagnosis and management.
Purpose of the Study:
- To evaluate the efficacy of the Virtual Supermarket (VST), a novel tablet-based tool, in assessing cognitive functioning in patients with SVD.
- To compare cognitive performance between SVD patients with cognitive impairment (SVD-CI), cognitively normal SVD patients (SVD-CN), and healthy controls (HC) using the VST.
Main Methods:
- Administered the tablet-based VST application alongside traditional neuropsychological tests to assess memory, attention, executive function, visuospatial function, and language.
- Included participants with SVD-CI (N=32), SVD-CN (N=37), and age/education-matched HC (N=30) in the study.
Main Results:
- Found moderate correlations between VST variables (Duration, Correct Quantities) and visuospatial function/general cognitive status in SVD-CI patients.
- Observed moderate relationships between VST variables (Duration, Correct Money) and memory, executive functions, and visuospatial function in SVD-CN patients.
- The VST successfully discriminated between SVD-CI and HC with 81% accuracy, 78% sensitivity, and 84% specificity when using a combination of VST variables.
Conclusions:
- This study is the first to utilize the VST for evaluating cognitive functions in SVD patients with and without cognitive impairment.
- The VST demonstrates potential as a valuable screening tool for identifying cognitive impairment and differentiating SVD patients from healthy individuals.
- Further validation studies with larger sample sizes are recommended to confirm the VST's utility in clinical practice.

